Literature DB >> 3513771

Food-induced (allergic) arthritis. Inflammatory arthritis exacerbated by milk.

R S Panush, R M Stroud, E M Webster.   

Abstract

Suggestive, but largely unproven, observations have associated arthritis with environmental antigens, including foods. We studied a patient with inflammatory arthritis in a prospective, "blinded," controlled fashion to determine whether her symptoms were associated with food sensitivities. This 52-year-old white woman with 11 years of class I, stage I, active disease, had symptomatic exacerbations allegedly associated with meat, milk, and beans. We observed an increase in symptoms following an unblinded food challenge and then studied her in our clinical research unit. On her normal diet for 6 days, she averaged 30 minutes of morning stiffness, 9 tender joints, 3 swollen joints, 87% subjective assessment (100% = best possible), and 89% examiner assessment. While she was fasting (3 days) or taking Vivonex (2 days), we noted no morning stiffness, tender joint score of 1, swollen joint score of 0, and assessments of 100% (P less than 0.05 versus normal diet). She was then nourished with Vivonex for 33 days without difficulty and challenged in a blinded fashion at mealtimes with lyophilized foods placed into opaque capsules. Four milk challenges (equivalent to greater than or equal to 8 ounces per meal) produced up to 30 minutes of morning stiffness, 14 tender joints, 4 swollen joints, subjective assessment of 85%, and objective assessment of 80% (P less than 0.05 versus fasting-Vivonex), peaking 24-48 hours postchallenge. Placebo and other foods (lettuce and carrots) were without effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513771     DOI: 10.1002/art.1780290210

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

1.  Food intolerance in rheumatoid arthritis. I. A double blind, controlled trial of the clinical effects of elimination of milk allergens and azo dyes.

Authors:  M A van de Laar; J K van der Korst
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  Food intolerance in rheumatoid arthritis. II. Clinical and histological aspects.

Authors:  M A van de Laar; M Aalbers; F G Bruins; A C van Dinther-Janssen; J K van der Korst; C J Meijer
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

3.  Vegetarian diet for patients with rheumatoid arthritis--status: two years after introduction of the diet.

Authors:  J Kjeldsen-Kragh; M Haugen; C F Borchgrevink; O Førre
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

Review 4.  Altered gut microbiota in RA: implications for treatment.

Authors:  Y Kang; Y Cai; X Zhang; X Kong; J Su
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

5.  Effects of fish oil supplementation in rheumatoid arthritis.

Authors:  H van der Tempel; J E Tulleken; P C Limburg; F A Muskiet; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

6.  Food allergy in patients with rheumatoid arthritis.

Authors:  M Felder; A C De Blecourt; B Wüthrich
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

7.  Diet and disease symptoms in rheumatic diseases--results of a questionnaire based survey.

Authors:  M Haugen; J Kjeldsen-Kragh; B Y Nordvåg; O Førre
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

8.  Effect of dietary restrictions on disease activity in rheumatoid arthritis.

Authors:  D Beri; A N Malaviya; R Shandilya; R R Singh
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

9.  Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis.

Authors:  L Kanerud; G N Engström; A Tarkowski
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

10.  Mast cells as a target in the treatment of rheumatoid arthritis.

Authors:  O Bakharevski; P F Ryan
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.